Search

everythinglearnresearchcommunity

for

Search:↓

Certain health conditions and hair care habits affect the treatment results for a scalp condition called Central Centrifugal Cicatricial Alopecia.

Women with conditions like PCOS may have a higher risk of COVID-19, but treatments like isotretinoin could help those with acne.

Tofacitinib helped most patients with alopecia areata regrow hair and changes in immune cells were linked to the treatment's effectiveness.

Dermoscopy improves accuracy in predicting treatment success for androgenetic alopecia with the Regenera® protocol.

Deucravacitinib improves symptoms and reduces inflammation in Lichen Planopilaris.

Preoperative stress markers alone don't predict chronic post-surgical pain.

GT20029 showed some hair growth improvement, but longer studies are needed for better results.

Bariatric surgery improved quality of life and health in six months, but hair loss was common.

FUE technique offers higher satisfaction and broader use for women needing hair transplants.

Iron-deficiency anemia in pregnancy can cause serious health issues for both mother and baby.

Photobiomodulation may improve certain health conditions, but more high-quality research is needed.

Patient-reported hair improvements align with actual hair density changes, not hair width.

Exosome treatment safely increases hair density in male patients with androgenetic alopecia.

5-alpha reductase inhibitors don't increase breast cancer or benign breast disorder risk in women.

IBD patients treated with TNF antagonists may develop autoimmune alopecia areata, with severe cases less likely to improve.

A higher genetic risk score increases the chance of getting benign prostatic hyperplasia and affects treatment outcomes in Han Chinese men.

Some factors like thyroid disease, diabetes treatment, hair dryers, natural hairstyles, and scalp conditions can affect the treatment results for a hair loss condition called CCCA.

Hormone replacement therapy may lower the risk of severe COVID-19 outcomes in non-immunosuppressed people and male organ transplant recipients.

Increased TEMRA cells can predict treatment outcomes in rapidly progressive alopecia areata.

Sleeve gastrectomy leads to significant weight loss and health improvements with few complications.

Nutritional education reduces chemotherapy side effects and improves health in breast cancer patients.

CTCL patients can safely continue treatment during COVID-19 with proper safety measures.

The data suggests that dosing differences can help manage spasticity in patients with upper motor neuron dysfunction.

PRP treatment effectively improves hair density and thickness in people with androgenic alopecia.

Propecia users with Androgenic Alopecia experienced a lower quality of life and more serious side effects compared to those using Minoxidil.

Clinical trials for alopecia areata need better inclusion and retention of patients of color.

Anti-androgens, like finasteride, dutasteride, and spironolactone, may lessen the severity of COVID-19 in men, leading to fewer ICU admissions.